Linkage Biosciences Announces Expansion
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 12/22/14 -- Linkage Biosciences, a leading manufacturer of tissue transplantation diagnostic products, announced a new long-term agreement to add manufacturing, research and development, and office space in South San Francisco, California.
"We''re pleased Linkage Biosciences has chosen to continue to grow in South San Francisco," said South San Francisco Mayor Richard Garbarino. "We hope that they will grow in our City for many more years. We take pride in seeing our innovative companies succeed. Linkage''s technology platform is critical to the future development of medicine and drugs, improving the health of all our residents and people on a global basis."
"We doubled our staff last year and continue to prepare for more growth," said Zachary Antovich, CEO of Linkage Biosciences. "This new, custom-designed space will integrate into our manufacturing system and increase our overall production capacity to meet the needs of our expanding customer base."
In concert with the expanded facilities announcement, Linkage Biosciences also announced that Ms. Hamutal Anavi Russo has joined the company as Chief Financial Officer. Ms. Russo brings over 15 years of experience in financial management for both medical device and enterprise software companies. Previously, as CFO of OrSense, she was part of the executive team marketing the world''s first non-invasive hemoglobin blood monitoring product.
About Linkages Biosciences
Linkage Biosciences, Inc. is a molecular diagnostics company developing and marketing products that dramatically improve and expedite complex genetic testing. LinkS?q™ is the company''s exclusive and unique HLA tissue typing technology, which is used in immunogenetics research and histocompatibility testing. The company is headquartered in South San Francisco, California. To learn more please visit
Copyright 2014. Linkage Biosciences, Inc. All rights reserved.
Linkage Biosciences and LinkS?q are trademarks of Linkage Biosciences, Inc.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.12.2014 - 07:30 Uhr
Sprache: Deutsch
News-ID 1326843
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN FRANCISCO, CA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 272 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Linkage Biosciences Announces Expansion
"
steht unter der journalistisch-redaktionellen Verantwortung von
Linkage Biosciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
